Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Thukral J, Moudgil P, Sindhwani N, et. al. "Clonal Cytopenias of Undetermined Significance and Cardiovascular Disease: Inflammatory Mechanisms, Risk Stratification, and Clinical Outcomes." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001267
- Kaiser ME, Farmer BM, Parikh MA, et. al. "Genetically Modified Foods: Have They Reduced Cardiovascular Risk?" Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001226
- Whitford T, Wasserstein DH, Whiteson H, et. al. "Lymphedema: The Overlooked Cardiovascular Disorder-Mechanisms, Manifestations, and Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001201
- Thukral J, Moudgil P, Rohewal J, et. al. "Immune Checkpoint Inhibitor-Associated Myocarditis: Current Understanding of Clinical Presentation and Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001257
- Drogy MS, Minto ST, Frishman WH, et. al. "Metabolic Dysfunction-Associated Steatotic Liver Disease and Atherosclerotic Cardiovascular Disease: Shared Pathophysiology, Biomarkers, and Emerging Therapeutic Strategies." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001259
- Richards M, Tetelbaun L, Frishman WH, et. al. "Danon Disease: Clinical Manifestations, Pathophysiology, and Treatment." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001253
- Thukral J, Moudgil P, Ratol HK, et. al. "Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical Cardiotoxicity." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001255
